Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.

Faster global financial news!

The U.S. Department of Health and Human Services and the Drug Enforcement Administration announced that the flexibility policy regarding the telemedicine prescription of controlled substances will be extended through 2026.

02/01/2026 09:29 UTC
Share
Complaint Report
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
i
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.